Browsing: Homepage Slider
Oncology Central is hosting a free 2-day online educational symposium, chaired by Professor Angus Dalgleish (St George’s, University of London) aimed at delivering oncology professionals key updates in this field. This online symposium will be CME-accredited.
Editor, Jade Parker recently spoke with David Adams, Wellcome Trust Sanger Institute (Cambridge, UK) about utilizing DNA sequencing of patients and genetic screens in human cells and mice to identify cancer genes and genetic interactions.
In this infographic gain a visual snapshot of a review article in which over 50 leaders in the dermatology field critically assess current screening practice for melanoma in an effort to propose rational, risk-based, data-driven guidelines for skin cancer screening.
Editor Jade Parker, speaks to Peter Campbell (Wellcome Trust Sanger Institute, Cambridge, UK) to find out how he is working towards identifying the preventable causes of cancer.
In this interview find out about Anthony Nolan’s research strategy, breakthroughs that have aided the advancement of stem cell transplantation, how third-generation sequencing for HLA typing may improve donor-recipient matching and the direction that Alejandro Madrigal envisions Anthony Nolan’s research will take in the coming years.
Find out about how the UK’s National Physical Laboratory (NPL) is enabling greater confidence in radiotherapy, leading to accelerated implementation of the most advanced techniques and helping to ensure patients receive the same standard of treatment irrespective of where they receive their treatment.
Register now for webinar!
Live event: Wednesday 14th June 2017 at 07:00 [PST] 10:00 [EST] 15:00 [GMT]
Learn about a study that was accomplished as a means to explore the hypothesis that circulating concentrations of decoy receptors and/or ligands, as well as disease-specific ligand degradation all regulate RTK signaling in vivo.
Pat Garcia-Gonzalez and Ann Kim Novakowski from The Max Foundation speak to Sebastian Dennis-Beron, commissioning editor at Future Medicine, for Oncology Central.
To mark our focus on social media in cancer care we recently spoke with Deanna Attai from the University of California (CA, USA) about the potential use of social media in cancer care including how oncologists can incorporate social media into their care plans as well as the opportunities and risks they should be aware of